{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:12:43Z","timestamp":1790982763255,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.4158\/ep15748.dsc","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T16:36:25Z","timestamp":1446050185000},"page":"1291-1300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":453,"title":["American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1"],"prefix":"10.1016","volume":"21","author":[{"given":"Neil F.","family":"Goodman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda H.","family":"Cobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Futterweit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Glueck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Legro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP15748.DSC_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSC_bb0015","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1210\/jcem.82.6.9999","article-title":"Errors in the measurement of plasma free testosterone","volume":"82","author":"Rosner","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0020","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1210\/jcem.86.6.7643","article-title":"An extraordinarily inaccurate assay for free testosterone is still with us","volume":"86","author":"Rosner","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0025","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1210\/jcem.84.10.6079","article-title":"A critical evaluation of simple methods for the estimation of free testosterone in serum","volume":"84","author":"Vermeulen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1196\/annals.1365.011","article-title":"Ovarian and adrenal hyperandrogenism","volume":"1092","author":"Carmina","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.4158\/EP15748.DSC_bb0035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF03347408","article-title":"Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes","volume":"30","author":"Carmina","year":"2007","journal-title":"J Endocrinol Invest"},{"issue":"6 Pt 1","key":"10.4158\/EP15748.DSC_bb0040","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/0002-9378(91)90042-P","article-title":"Is 11 beta-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?","volume":"165","author":"Stanczyk","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.steroids.2009.01.004","article-title":"Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods","volume":"74","author":"Vesper","year":"2009","journal-title":"Steroids"},{"key":"10.4158\/EP15748.DSC_bb0050","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1530\/EJE-11-0482","article-title":"Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results","volume":"165","author":"Janse","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP15748.DSC_bb0055","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0060","doi-asserted-by":"crossref","first-page":"201.e1","DOI":"10.1016\/j.ajog.2010.03.008","article-title":"The diagnosis of polycystic ovary syndrome in adolescents","volume":"203","author":"Carmina","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0015-0282(98)00141-1","article-title":"Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama","volume":"70","author":"Azziz","year":"1998","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSC_bb0070","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0015-0282(98)00455-5","article-title":"Do hyperandrogenic women with normal menses have polycystic ovary syndrome?","volume":"71","author":"Carmina","year":"1999","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSC_bb0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0015-0282(16)46095-4","article-title":"The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle (\u201covulation\u201d) derived from treated and untreated conception cycles","volume":"37","author":"Hull","year":"1982","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSC_bb0080","first-page":"522","article-title":"Evaluation of ovulation and corpus luteum function using measurements of plasma progesterone","volume":"44","author":"Abraham","year":"1974","journal-title":"Obstet Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0085","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.steroids.2013.04.004","article-title":"Cancer risk and PCOS","volume":"78","author":"Dumesic","year":"2013","journal-title":"Steroids"},{"key":"10.4158\/EP15748.DSC_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-sponsored 3rd PCOS consensus workshop group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"10.4158\/EP15748.DSC_bb0095","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/humupd\/dms029","article-title":"Emotional distress is a common risk in women with polycystic ovary syndrome: a systematic review and meta-analysis of 28 studies","volume":"18","author":"Veltman-Verhulst","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP15748.DSC_bb0100","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1093\/humupd\/dmt061","article-title":"Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP15748.DSC_bb0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.4158\/EP15748.DSC_bb0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/09513590903247824","article-title":"Polycystic ovaries, as defined by the 2003 Rotterdam consensus criteria, are found to be very common in young healthy women","volume":"26","author":"Duijkers","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"10.4158\/EP15748.DSC_bb0115","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/uog.5393","article-title":"Ovarian volume and follicle number in the diagnosis of polycystic ovary syndrome in Chinese women","volume":"32","author":"Chen","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/eem.09.73","article-title":"Hirsutism: investigation and management","volume":"5","author":"Carmina","year":"2010","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0130","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1093\/humrep\/der297","article-title":"Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries","volume":"26","author":"Dewailly","year":"2011","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSC_bb0135","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/0002-9378(81)90746-8","article-title":"Hirsutism: implications, etiology, and management","volume":"140","author":"Hatch","year":"1981","journal-title":"Am J Obstet Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0140","doi-asserted-by":"crossref","first-page":"80S","DOI":"10.1016\/S0002-9343(99)80063-1","article-title":"Role of androgens in the developmental biology of the pilosebaceous unit","volume":"98","author":"Rosenfield","year":"1995","journal-title":"Am J Med"},{"key":"10.4158\/EP15748.DSC_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/00015550410023248","article-title":"Correlation between endocrinological parameters and acne severity in adult women","volume":"84","author":"Borgia","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.4158\/EP15748.DSC_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1346-8138.1997.tb02778.x","article-title":"Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne","volume":"24","author":"Timpatanapong","year":"1997","journal-title":"J Dermatol"},{"key":"10.4158\/EP15748.DSC_bb0155","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/1523-1747.ep12539043","article-title":"Plasma androgens in women with acne vulgaris","volume":"81","author":"Lucky","year":"1983","journal-title":"J Invest Dermatol"},{"key":"10.4158\/EP15748.DSC_bb0160","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4158\/EP.7.2.120","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical practice for the diagnosis and treatment of hyperandrogenic disorders","volume":"7","author":"Goodman","year":"2001","journal-title":"Endocr Pract"},{"key":"10.4158\/EP15748.DSC_bb0165","first-page":"CD000194","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","volume":"2","author":"Brown","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.4158\/EP15748.DSC_bb0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","article-title":"Effects and side-effects of spironolactone therapy in women with acne","volume":"19","author":"Yemisci","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.4158\/EP15748.DSC_bb0175","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1468-3083.2010.03758.x","article-title":"5 mg\/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss","volume":"25","author":"Yeon","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.4158\/EP15748.DSC_bb0180","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/gye.17.1.57.63","article-title":"The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism","volume":"17","author":"Lakryc","year":"2003","journal-title":"Gynecol Endocrinol"},{"key":"10.4158\/EP15748.DSC_bb0185","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4158\/EP11117.RA","article-title":"The Hirsute woman: challenges in evaluation and management","volume":"17","author":"Paparodis","year":"2011","journal-title":"Endocr Pract"},{"key":"10.4158\/EP15748.DSC_bb0190","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1001\/archderm.142.3.298","article-title":"Finasteride treatment of female pattern hair loss","volume":"142","author":"Iorizzo","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.4158\/EP15748.DSC_bb0195","first-page":"637","article-title":"Effective treatment of female androgenic alopecia with dutasteride","volume":"4","author":"Olszewska","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.4158\/EP15748.DSC_bb0200","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2013.01.005","article-title":"Polycystic ovarian syndrome during puberty and adolescence","volume":"373","author":"Williams","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.4158\/EP15748.DSC_bb0210","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2013.04.011","article-title":"Diagnosis of adolescent polycystic ovary syndrome","volume":"78","author":"Hardy","year":"2013","journal-title":"Steroids"},{"key":"10.4158\/EP15748.DSC_bb0215","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","article-title":"Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis","volume":"26","author":"Hickey","year":"2011","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSC_bb0220","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1365-2125.2011.04063.x","article-title":"Unlicensed use of metformin in children and adolescents in the UK","volume":"73","author":"Hsia","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.4158\/EP15748.DSC_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1687-9856-2011-9","article-title":"State of the art review: emerging therapies: the use of insulin sensitizers in the treatment of adolescents with polycystic ovary syndrome (PCOS)","volume":"2011","author":"Geller","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.4158\/EP15748.DSC_bb0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.160.3.241","article-title":"Randomized placebo-controlled trial of metformin for adolescents with polycystic ovary syndrome","volume":"160","author":"Bridger","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.4158\/EP15748.DSC_bb0235","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpeds.2012.11.019","article-title":"Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents","volume":"162","author":"Roe","year":"2013","journal-title":"J Pediatr"},{"key":"10.4158\/EP15748.DSC_bb0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.12028","article-title":"Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome","volume":"79","author":"Bredella","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP15748.DSC_bb0245","first-page":"671","article-title":"Premature adrenarche--normal variant or forerunner of adult disease?","volume":"21","author":"Ib\u00e1\u00f1ez","year":"2000","journal-title":"Endocr Rev"},{"key":"10.4158\/EP15748.DSC_bb0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ib\u00e1\u00f1ez","year":"2004","journal-title":"J Pediatr"},{"key":"10.4158\/EP15748.DSC_bb0255","doi-asserted-by":"crossref","first-page":"E1262","DOI":"10.1210\/jc.2011-0555","article-title":"Early metformin therapy (age 8\u201312 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence","volume":"96","author":"Ib\u00e1\u00f1ez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15748.DSC_bb0260","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/humrep\/dei004","article-title":"Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women","volume":"20","author":"Ib\u00e1\u00f1ez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.4158\/EP15748.DSC_bb0265","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpag.2011.11.010","article-title":"Effect of antiandrogen treatment on bone density and bone geometry in adolescents with polycystic ovary syndrome","volume":"25","author":"Bechtold","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.4158\/EP15748.DSC_bb0270","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2265.2012.04466.x","article-title":"Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome","volume":"78","author":"Harmanci","year":"2013","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20353222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:59:00Z","timestamp":1761515940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20353222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1530891X20353222"],"URL":"https:\/\/doi.org\/10.4158\/ep15748.dsc","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP15748.DSC","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}